ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $166,579 | -18.8% | 30,565 | 0.0% | 0.02% | -11.1% |
| Q2 2023 | $205,091 | -24.2% | 30,565 | -0.3% | 0.02% | -30.8% |
| Q1 2023 | $270,640 | +15.6% | 30,650 | 0.0% | 0.03% | +13.0% |
| Q4 2022 | $234,166 | +7.4% | 30,650 | 0.0% | 0.02% | 0.0% |
| Q3 2022 | $218,000 | -50.2% | 30,650 | -43.3% | 0.02% | -45.2% |
| Q2 2022 | $438,000 | +8.7% | 54,100 | +86.6% | 0.04% | +31.2% |
| Q1 2022 | $403,000 | -48.7% | 29,000 | +3.6% | 0.03% | -47.5% |
| Q4 2021 | $786,000 | -17.4% | 28,000 | 0.0% | 0.06% | -23.8% |
| Q3 2021 | $952,000 | -16.8% | 28,000 | 0.0% | 0.08% | -12.1% |
| Q2 2021 | $1,144,000 | +1.5% | 28,000 | 0.0% | 0.09% | -6.2% |
| Q1 2021 | $1,127,000 | -31.9% | 28,000 | 0.0% | 0.10% | -38.6% |
| Q4 2020 | $1,656,000 | +21.6% | 28,000 | 0.0% | 0.16% | +11.3% |
| Q3 2020 | $1,362,000 | +0.5% | 28,000 | 0.0% | 0.14% | -7.8% |
| Q2 2020 | $1,355,000 | – | 28,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIGER MANAGEMENT L.L.C. | 1,115,411 | $45,576,000 | 7.97% |
| Rappaport Reiches Capital Management, LLC | 133,330 | $5,447,864 | 5.73% |
| Matrix Capital Management Company, LP | 11,800,090 | $482,152,000 | 5.27% |
| Asymmetry Capital Management, L.P. | 168,172 | $6,872,000 | 4.72% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $1,225,543,000 | 3.72% |
| Eagle Health Investments LP | 257,827 | $10,535,000 | 3.61% |
| BERYLSON CAPITAL PARTNERS, LLC | 246,200 | $10,060,000 | 2.23% |
| Aristotle Atlantic Partners, LLC | 717,650 | $29,323,000 | 1.93% |
| DDD Partners, LLC | 250,382 | $10,231,000 | 1.55% |
| Casdin Capital, LLC | 1,440,000 | $58,838,000 | 1.49% |